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Abstract
Introduction and hypothesis The objective of this study
was to report 1 year anatomical and functional outcomes of
trocar-guided total tension-free vaginal mesh (Prolift™)
repair for post-hysterectomy vaginal vault prolapse with
one continuous piece of polypropylene mesh.
Methods We conducted a prospective observational cohort
study of 46 patients. A minimum sample size of 35 patients
was needed to detect a recurrence rate of less than 20% at
12 months. Instruments of measurement used were pelvic
organ prolapse quantification and validated questionnaires.
Results Overall anatomical success was 91% (95% confi-
dence interval 83–99), with significant improvement in
experienced bother and quality of life. Mesh exposure
occurred in seven patients (15%). No adverse effects on
sexual function could be detected.
Conclusions Trocar-guided total tension-free vaginal mesh
(Prolift™) repair with one continuous piece of mesh for
post-hysterectomy vaginal vault prolapse is well tolerated
and anatomically and functionally highly effective. Results
of controlled trials will determine its position in the
operative armamentarium.
Keywords Exposure.Mesh.Tension-free.Totalrepair.
Trocar-guided.Vaultprolapse
Abbreviations
POP-Q pelvic organ prolapse quantification
UDI urogenital distress inventory
DDI defaecatory distress inventory
IIQ incontinence impact questionnaire
PGI-I patients global impression of improvement
POP pelvic organ prolapse
Introduction
Pelvic organ prolapse (POP) in women is common,
affecting 50% of parous women over 50 years of age, with
a lifetime prevalence risk of 30–50% [1]. A challenging
aspect of POP is the treatment of the prolapsed vaginal
vault. The incidence of post-hysterectomy vaginal wall
prolapse that requires surgery has been estimated at 1.3 per
1,000 women-years.
The risk of prolapse surgery was 4.7 times higher in
women whose initial hysterectomy was indicated by
prolapse and 8.0 times higher if preoperative prolapse stage
II or more was present [2].
The surgical treatment of vaginal vault prolapse can
either be performed by vaginal or abdominal route. A
prospective randomised clinical trial of vault prolapse,
which compared the abdominal sacral colpopexy with the
vaginal sacrospinous colpopexy, showed similar results in
both groups with regards to subjective and objective
postoperative anatomical assessment and impact on quality
of life, but found that the abdominal route was associated
with a longer operating time, slower return to activities of
daily living, and greater cost than the vaginal sacrospinous
colpopexy [3]. Both techniques have some drawbacks.
Prolapse of the anterior compartment following sacrospi-
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abdominal sacral colpopexy are well reported [4, 5]. On the
other hand, treatment of the anterior and/or posterior
compartment alone will invariably affect the vaginal vault
[6]. The ideal solution, therefore, would be a surgical
approach with minimal morbidity that simultaneously treats
all three compartments with equal success.
A number of synthetic implant materials with surgical
instrument kits are currently commercially available. The
rationale for using these is to decrease surgical failures. One
such surgical kit is designed for the total vaginal repair of
vault prolapse with one continuous mesh interposition on
the anterior, apical, and posterior compartment. It aims to
be a bilateral sacrospinous ligament suspension as well
(Prolift™, Ethicon, Somerville, NJ, USA). The first data on
the efficacy and safety of this novel transvaginal mesh
technique are reported from retrospective case series and do
not explicitly focus on this total vaginal mesh treatment
with one continuous mesh for vault prolapse [7, 8].
Prospective data on this tension-free vaginal mesh tech-
nique were scarce and with short-term follow-up [9]. Only
one paper on trocar-guided vaginal mesh repair shows a
prospective follow-up of 1 year, but the authors do not
discriminate between the combined anterior and posterior
repair with preservation of the uterus and a true total repair
with one continuous mesh for vaginal vault prolapse [10].
The aim of this paper is to exclusively report on the
efficacy and safety of the total tension-free vaginal mesh
(Prolift™) repair with one continuous piece of mesh for the
anterior, apical, and posterior compartment in case of post-
hysterectomy vaginal wall prolapse.
Materials and methods
In September 2005, an ongoing prospective observational
cohort study with the Prolift™ pelvic floor repair system
was started in two urogynaecological centres in The
Netherlands: the Reinier de Graaf Hospital in Delft and
the Radboud University Nijmegen Medical Centre.
After obtaining informed consent, consecutive patients
with recurrent vaginal wall prolapse stage II or more, or
with a primary vaginal wall prolapse stage III or more were
enrolled in this study. Two hundred ninety-seven patients
were included at the beginning of 2009. One hundred
ninety-six patients (66%) had completed their 1 year
follow-up. Of those, 46 patients (24%) underwent the total
continuous vaginal mesh procedure for vault prolapse.
Surgical procedures were performed by four surgeons who
were trained prior to the start of the study. Most
postmenopausal patients were treated with topical oestro-
gen 6–8 weeks prior to surgery and continued this treatment
postoperatively when considered necessary. Concomitant
anti-incontinence surgery was not performed in this patient
series in order to prevent increased risk of complications as
reported earlier by us [11]. All patients were counselled
about this strategy prior to surgery.
Preoperatively, genital prolapse was quantified in the
dorsal lithotomy position using the pelvic organ prolapse
quantification (POP-Q) measurement system [12]. Postop-
eratively, POP-Q measurements were performed at both 6
and 12 months.
Surgical procedure
Preoperative antibiotic prophylaxis was given with a single
dose of cefalozine-natrium (Kefzol
® Lilly, The Netherlands)
and metronidazole (Flagyl
® Aventis Pharma BV Hoevelaken,
The Netherlands). Patients were positioned in the dorsal
lithotomy position with their hips flexed to about 110°. The
anus was covered with Tegaderm
®. After liberal use of
hydrodissection (lidocaine hydrochloride monohydrate
200 mg with epinephrine hydrogen tartrate 100 μgi n
20 ml—Astra Zeneca BV Zoetermeer, The Netherlands—
diluted in 100 ml of 0.9% saline solution), an anterior
midline incision was made which included full thickness of
the fibromuscular wall of the vagina from about 2.5 cm distal
from the external urethral meatus to about 2 cm distal of the
vaginal apex. Bilateral, mostly blunt, and incidentally sharp
dissection was used to open the vesicovaginal fascia in order
to reach distally the cranial side of the ischial spine, the arcus
tendineus fascia pelvis, and the retropubic space.
The transobturator insertion of the cannula-equipped
guides, and retrieval devices have been extensively de-
scribed elsewhere and were not altered in our hands [7].
After hydrodissection of the posterior vaginal wall, a full
thickness vaginal wall incision was made to the vaginal
apex leaving an apical bridge of vaginal tissue of about
3 cm from the anterior incision. The pararectal space was
bilaterally bluntly dissected until the caudal side of the
ischial spines were reached and the sacrospinous ligaments
were properly identified. The cannula-equipped guides
were used to perforate and pass the sacrospinous ligaments
about 2 cm medially from the ischial spines as described in
the paper by Fatton et al. [7]. A channel was carefully
dissected under the apical bridge of the vaginal vault in
order to allow passage of the posterior part of the total
Prolift™ mesh. Gloves were changed to minimise coloni-
sation of bacteria and decrease infection risk. A slender
forceps was used to gently pull the posterior part of the
mesh through the previously dissected channel at the level
of the vault in such a manner that the middle part of the
mesh exactly fitted under this bridge of vaginal tissue
(Fig. 1). After fixation of the mesh with two Vicryl 00
sutures at the level of the bladder neck and two Vicryl 00
sutures close to the posterior vaginal commissure, the four
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through the cannulas by the respective retrieval devices. The
meshwascarefullyspreadtoavoidunnecessarymeshfolding,
after which, the full thickness of the anterior and posterior
vaginal walls were closed with a running Vicryl 00 suture,
without prior vaginal wall dissection. After repositioning the
vaginawithtwoBreiskyspeculatoitsanatomicalposition,the
cannulas were carefully withdrawn, and a finger in the rectum
gently lifted the posterior mesh with the intention of
preventing subsequent tension on the rectum, following
possible shrinkage of the mesh. The cutaneous remnants of
the mesh arms were cut, and the small skin incisions closed
with rapidly dissolving Vicryl 000 suture. An iodized gauze
pack was left in the vagina for at least 24 h. The indwelling
urinarycatheterwasremovedonthesecondpostoperativeday.
Study endpoints
We defined the primary endpoint of this study to be
prolapse recurrence at 12 months. Anatomical failure was
defined if at least one of the compartments at 12 months
was classified as POP ≥stage II. Anatomical success was
defined as overall POP stage 0 or I.
Secondary endpoints were anatomic success per compart-
ment, peri- and postoperative morbidity, change in experi-
enced bother, quality of life, and global impression of change
at 6 and 12 months, as well as effects on sexual function.
Sample size
We defined study success as an upper 95% confidence
interval (CI) for recurrence <20% at 12 months. We
assumed that an estimated success of 90% at 12 months
in the mesh-treated compartments would be realistic [8].
With this estimated 90% success rate, a two-sided 95% CI
of 10% was allowed, which meant that we needed a
minimum sample size of 35 patients for this study.
Data collection
To obtain data on the functional efficacy and impact on
patients’ quality of life, the standard urogynaecological
questionnaire of the Dutch Pelvic Floor Society was used at
baseline and at 6 and 12 months, postoperatively. This
questionnaire contains the validated Dutch versions of the
pelvic floor distress inventory (urogenital distress inventory
(UDI) and defaecatory distress inventory (DDI)), the pelvic
floor impact questionnaire (incontinence impact question-
naire (IIQ)), patients global impression of improvement
(PGI-I), and questions on sexual functioning [13, 14]. All
data were entered into a Statistical Package for the Social
Sciences 16.0 database. Baseline and surgical data are
presented as median (range), complications as numbers
with corresponding percentages. Differences in numbers
were tested using Pearson’s chi-square test.
Mean domain scores and standard deviations were
calculated on the domains of UDI, DDI, and IIQ. Differ-
ences in means between baseline and postoperative scores
at 6 and 12 months were tested with the paired-samples t
test. A p value ≤0.05 was considered statistically significant.
Results
Forty-six consecutive patients who were operated using the
total vaginal mesh procedure (Prolift™)f o rp o s t -
hysterectomy vaginal wall prolapse were analysed. For
various reasons, we missed seven patients at the 6 months
visit. At the 12 months visit, one patient refused to come
for POP-Q examination, since she claimed to have no
complaints. We could not convince her of the usefulness of
this check-up. She was willing though to send us her
completed questionnaire. One other patient was not able to
complete her 12 months questionnaire because of progres-
sive cerebral dementia, but was willing to be examined for
POP-Q measurements. Median age was 66 (38–86) years.
All but one patient (98%) had undergone previous prolapse
surgery, of whom, four (9%), more than once. Baseline and
other surgical characteristics are presented in Table 1.
Anatomical results
Baseline, 6, and 12 months data per POP-Q variable,
overall POP stage, and POP stage per compartment are
shown in Table 2. At baseline, 40 patients (87%) were
classified as having a vaginal prolapse with the leading
edge at POP stage III or IV and six (13%) at stage II.
Fig. 1 Total mesh in position under the vaginal apical bridge
Int Urogynecol J (2009) 20:1203–1211 1205Twelve months after surgery, 41 out of 45 patients (91%:
95% CI 83–99) fulfilled the criteria of an overall anatomically
successfulrepair.Four(9%)werethusclassifiedasanatomical
failures. One of these was classified as stage III (C+4). She
later underwent an abdominal sacral colpopexy. Mean
changes frombaselineper POP-Qvariableat6and12months
are shown in Table 2 as well. All changes are considerable
and significant. The size of the genital hiatus decreased
significantly with more than 1 cm, although surgery on the
vaginal introitus was performed in none. The mean total
vaginal length decreased by a statistically significant 0.3 cm
but seemed to be not clinically significant.
Morbidity
There were no bladder or rectal perforations in this patient
series as is seen in Table 1. Two patients presented
postoperatively with haematoma in the buttock region, which
resolved spontaneously within 10 days. A total number of
seven patients (15%) were found to have a small mesh
exposure, four at the 6 months follow-up and another three at
the 12 months visit. Three of these mesh exposures were
located on the anterior scar, two close to the level of the vault,
and two in the posterior scar. All of these were asymptomatic
andmeasuredbetween5and20mminsize.Allsevenpatients
wereinitially treatedwithtopical estrogens, and for reasons of
insufficient healing, the tiny mesh exposure was excised in
five patients in a day-care procedure. The two other patients
preferred expectant management.
Functional results
In Table 3, data on sexual function at baseline and 12 months
are shown. The percentages of patients reporting dyspareunia
before and after operation were equal (37%). De novo
dyspareunia occurred in two patients (18%). In another two
(28%), however, dyspareunia disappeared after surgery.
Table 4 shows functional data in the domains of UDI,
DDI, and IIQ as well as PGI-I [13, 14]. Scores ranged
between 0 (least bother and best quality of life) to 100
(maximum bother and worst quality of life). Six and
12 months after surgery, 94% and 93% of patients,
respectively, stated to be much better to very much better
compared to their baseline situation.
Discussion
To our knowledge, this is the first study of considerable size
that prospectively and specifically evaluates the efficacy and
safety of the total tension-free vaginal mesh repair using one
continuouspieceofpolypropylenemeshforallthreecompart-
ments of the prolapsed vaginal vault. The Prolift™ total
prolapserepairsystemisuniqueinthisrespect,and atpresent,
theonlyavailablesurgicalkitthatoffersthepossibilityofsuch
a comprehensive repair. It aims at support of the weakened
vaginal walls of the anterior and posterior compartments and
suspension of the apical compartment by means of a bilateral
sacrospinous ligament fixation thus restoring Delancey level I
support [15]. Other mesh kits are designed to treat the
anterior and posterior compartments, either alone or simul-
taneously, with a separate (split) mesh. Suspension of the
vault in these procedures is not achieved by a bilateral
sacrospinous ligament fixation, but by means of bilateral
infracoccygeal sacropexy as described by Petros [16]. Most
data on these procedures are derived from congress abstracts,
retrospective reports, or studies with short follow-up [7, 9,
17]. Only a few data are published with a medium long-term
follow-up, but none of these focuses exclusively on the total
repair with one continuous piece of mesh [8, 10].
Table 1 Baseline, surgical characteristics, and complications
Patient characteristics and complications
Baseline characteristics (n=46)
Age (years) 66 (38–86)
Body mass index (kg/m
2) 25 (21–32)
Parity (n)2 ( 0 –5)
Postmenopausal 43 (93%)
Abdominal hysterectomy 13 (28%)
Prior prolapse related surgery 45 (98%)
• Vaginal hysterectomy 33 (72%)
• Anterior repair 25 (54%)
• Posterior repair 21 (46%)
• More than one prolapse repair 4 (9%)
Prior surgery for incontinence 3 (7%)
Surgical characteristics
Duration of surgery (min) 80 (54–109)
Blood loss (ml) 100 (50–1,300)
Spinal analgesia 21 (46%)
General anaesthesia 25 (54%)
Duration of stay indwelling catheter (days) 2 (1–6)
Hospital stay (days) 4 (3–8)
Complications
>500 ml blood loss 2 (4%)
Bladder lesion 0
Rectal lesion 0
Postoperative hematoma 2 (4%)
Urinary retention after removal catheter 8 (17%)
Accumulated mesh exposure (12 months) 7 (15%)
• Exposure in anterior compartment 3
• Apical exposure 2
• Exposure in posterior compartment 2
Data are presented as median (range) or number (percentage)
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Considering the high percentage of patients with recurrent
prolapse (98%) and high stage POP (III and IV) in this
study group at baseline (87%) and the follow-up period of
1 year, the overall anatomical success of 91% is respect-
able. This is also reflected in the mean changes of the three
most relevant POP-Q variables (Ba, C, and Bp) between
baseline and 12 months, which even exceed those reported
by other authors [8]. Anatomical success rates per com-
partment are comparable with that report.
Anatomical results in this study seem more promising
than those reported by the Scandinavian group, who
reported 79–82% for the anterior compartment and 81–
86% for the posterior compartment [10]. Neither of these
authors, however, makes a distinction between the
combined anterior and posterior mesh treatment and
one with a continuous piece of mesh. A clear comparison
is therefore not possible. The Scandinavian group
reported the combined results of 26 participating centres,
while we report on only two major centres. Therefore,
the number of procedures performed per surgeon and
possibly the experience related to this might be different.
Only one other minor study reported on 21 Prolift™ total
repairs with a continuous piece of mesh and showed an
anatomical success of 87% at 12 months [18]. The fairly
Table 2 Anatomical data per pelvic organ prolapse quantification variable and pelvic organ prolapse stage at baseline, 6, and 12 months
POP-Q
variable
Baseline
(n=46)
Six months
(n=39)
Change from
baseline
Twelve months
(n=45)
Change from
baseline
Ba 3.0 (2.6) −2.7 (0.5) 5.3 (2.2)
a −2.5 (1.1) 5.4 (2.4)
a
C −0.2 (4.7) −7.4 (1.5) 6.5 (4.2)
a −7.1 (2.3) 6.7 (4.6)
a
Bp 1.9 (2.9) −2.6 (0.7) 3.9 (2.3)
a −2.4 (1.2) 4.2 (2.6)
a
TVL 8.8 (1.2) 8.5 (1.1) 0.2 (1.2) 8.5 (1.2) 0.3 (0.9)
b
GH 4.8 (1.3) 3.5 (1.0) 1.3 (1.3)
a 3.5 (1.0) 1.2 (1.4)
a
PB 3.5 (1.2) 3.5 (0.9) 0.0 (1.0) 3.5 (0.9) 0.0 (1.0)
POP stage Baseline Success at 6 months Success at 12 months
Anterior 0 – 26 (66.7%) 100% 31 (68.9%) 95.6%
I 2 (4.3%) 13 (33.3%) 12 (26.7)
II 12 (26.1%) – 1 (2.2%)
III 30 (65.2%) – 1 (2.2%)
IV 2 (4.4%) ––
Apical 0 1 (2.2%) 33 (84.6%) 97.4% 36 (80%) 95.6%
I 25 (54.3%) 5 (12.8%) 7 (15.6%)
II 3 (6.5%) 1 (2.6%) 1 (2.2%)
III 14 (30.4%) – 1 (2.2%)
IV 3 (6.6%) ––
Posterior 0 1 (2.2%) 26 (66.7%) 94.9% 30 (66.7%) 91.1%
I 3 (6.5%) 11 (28.2%) 11 (24.4%)
II 20 (43.5%) 2 (5.1%) 3 (6.7%)
III 20 (43.5%) – 1 (2.2%)
IV 2 (4.3%) ––
Overall 0 – 15 (38.5%) 94.9% 15 (33.3%) 91.1% (82.8–99.4)
c
I – 22 (56.4%) 26 (57.8%)
II 6 (13%) 2 (5.1%) 3 (6.7%)
III 37 (80.5%) – 1 (2.2%)
IV 3 (6.5%) ––
Data are presented as mean (±standard deviation) for POP-Q variable and as number (percentage) for POP stage
All in centimetre distance from the hymenal remnants
Ba most descendant point at anterior vaginal wall, C vaginal apex, Bp most descendant point at posterior vaginal wall, TVL total vaginal length,
GH genital hiatus, PB perineal body length in centimetre (±standard deviation)
aP level <0.001 (paired-samples t test)
bP level 0.018 (paired-samples t test)
cNinety-five percent confidence interval
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95% CI rather wide (14%) and results less comparable.
The success rate of95% for restoration oflevel I support of
the apex is comparable with the 74–100% success rate of
apical support in abdominal sacrocolpopexy and the 89–97%
success rate for restoration of apical support by sacrospinous
ligamentfixation[19–21]. The advantage of this total vaginal
mesh procedure, however, is that it adds support to both
other vaginal compartments as well, and compared to the
abdominal sacrocolpopexy, has a shorter operation time and
can be considered as relatively minimally invasive treatment.
At 12 months, the measured total vaginal length was
a mean 0.3-cm shorter than at baseline. This slight
shortening probably is due to some shrinkage of the
mesh, which actually is not a shrinkage of the material
itself but rather a retraction because of fibrotic reactions
to the polypropylene mesh [22]. Although this slight
shortening is statistically significant, we, as other
authors, could not detect any clinical significance to this
finding [10]. If shrinkage continues, however, this could
become relevant in the future, so, longer follow-up is
mandatory.
Baseline Twelve months P*
Regular intercourse 19 of 42 (45%) 19 of 43 (44%) NS
Dyspareunia 7 of 19 (37%) A little 2 7 of 19 (37%) A little 2 NS
Rather much 3 Rather much 2
Very much 2 Very much 3
De novo dyspareunia 2 of 11 (18%) A little 1
Rather much 1
Resolved dyspareunia 2 of 7 (28%)
De novo intercourse 3 of 23 (13%)
Abstained intercourse 4 of 19 (21%)
Table 3 Data on sexual func-
tion at baseline and 12 months
Data presented as number of
patients (percentages)
aPearson chi-square test
Baseline Six months
(n=39)
P
a Twelve months
(n=45)
P
b
Domains UDI
Prolapse 69.1 (33.6) 0.4 (2.7) <0.001 2.3 (11.3) <0.001
Incontinence 24.2 (29.5) 16.2 (18.5) 0.250 14.2 (17.1) 0.122
Overactive bladder 31.6 (30.6) 10.5 (17.6) 0.002 11.1 (18.3) 0.001
Obstructive micturition 29.4 (29.9) 7.4 (17.6) 0.002 5.4 (11.3) <0.001
Pain 26.7 (28.4) 12.6 (20.6) 0.005 10.2 (17.7) 0.001
Domains DDI
Constipation 8.3 (14.6) 3.8 (9.1) 0.205 2.4 (6.9) 0.291
Obstructed defaecation 12.1 (17.2) 4.3 (8.9) 0.009 3.5 (7.7) 0.003
Pain 7.7 (19.0) 4.2 (12.8) 0.366 2.4 (10.8) 0.146
Incontinence 7.3 (13.5) 3.2 (7.8) 0.090 2.1 (6.7) 0.103
Domains IIQ
Physical functioning 32.5 (34.0) 8.1 (2.1) 0.002 9.3 (23.3) 0.001
Mobility 34.5 (25.8) 9.1 (12.7) 0.062 11.9 (20.2) <0.001
Emotional Health 23.1 (27.9) 5.2 (8.9) 0.002 9.9 (18.7) 0.001
Social Functioning 18.1 (18.9) 3.5 (7.8) 0.002 6.9 (13.7) <0.001
Embarrassment 16.7 (23.6) 2.8 (6.3) 0.016 7.8 (16.5) 0.062
Patients global
improvement
At 6 months At 12 months
Very much better 50% 48%
Much better 44% 45%
Little better 6% 5%
No change ––
Little worse – 2%
Table 4 Functional data on
domains of urogenital distress
inventory, defaecatory distress
inventory, incontinence impact
questionnaire at baseline, 6, and
12 months, and PGI-I
Scores range between 0 (least
bother and best quality of life) to
100 (maximum bother and worst
quality of life)
Values presented as means±
standard deviation
UDI urinary distress inventory,
DDI defaecatory distress inven-
tory, IIQ incontinence impact
questionnaire, PGI-I patients
global impression of improve-
ment (percentage of patients
with answer)
aP value between baseline and
6 months (paired-samples t test)
bP value between baseline and
12months (paired-samples t test)
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In this series of patients with a total Prolift™ repair, we
experienced no bladder or rectal injuries, which in the large
retrospective French series are well reported in percentages
of 0.7 and 0.15, respectively [23]. The rate of postoperative
hematomas in our series is comparable with those of the
Scandinavian and French reports [10, 23].
Mesh exposure
One important adverse effect of mesh surgery is the fairly
high number of mesh exposures. We found seven (15%)
after 12 months. Interestingly, we found none at the first
postoperative visit at 6 weeks, but four at 6 months, and
another three at the 12-month visit. Neither of these patients
was symptomatic. Therefore, a very careful follow-up even
beyond 12 months seems mandatory. The number of
exposures in the remaining 150 patients of our database
who completed their 12-month follow-up (at present data
are being processed) is 10% and not statistically significant
different from the percentage in this series (Pearson’s chi-
square 1.067; p=0.301). The Scandinavian group reported
similar findings: the erosion percentage rose from 7% at
2 months to 11% at 12 months [10]. A similar percentage
(11.3%) is also reported in the large retrospective French
series [23]. Since we are not aware of the natural
development of these most asymptomatic mesh erosions,
we felt the urge to treat them, initially with topical
estrogens, but as this was not sufficient in most cases, we
performed a minor mesh excision in five (11%) patients.
The remaining two patients who preferred expectant
management are still symptom-free.
Of these seven patients with a tiny mesh exposure, four
didn’t have intercourse at baseline, but one of these had
resumed intercourse at 6 months. One other patient
continued to have intercourse. Neither of both complained
of dyspareunia. Of three patients in whom a mesh exposure
was detected at the 12-month visit, two had intercourse at
baseline. At 12 months, one of these continued to have
intercourse without symptomatic dyspareunia, and the other
patient had abstained from intercourse for other reasons
than pain. Apparently, sexual intercourse in these patients
was not hindered by the presence of these minor mesh
exposures.
We found that the mean duration of surgery in the group
of patients who developed a mesh exposure (92±13) was
14 min longer than in those who did not (78±15). Whether
this is a significant item in this relatively small group of
patients remains unclear. This study, however, represents a
fairly complex group of patients with recurrent prolapse in
all but one case. The special technique which leaves a small
bridge of vaginal vault intact may jeopardise the vascular-
isation of the vaginal tissue and could be responsible for
poor wound healing and, thus, mesh exposure. In our
opinion, the rate of mesh exposures is still too high, and
determinants other than those already published need to be
discovered to lower this incidence [23–25].
Functional effects
Some earlier studies warned of the use of synthetic mesh in
prolapse surgery because of a high risk of dyspareunia [26].
Other authors, who used modern kits with low-weight
polypropylene designed by other companies, such as coated
polypropylene (Ugytex, Sofradim, France) or the Perigee
transobturator prolapse repair system (American Medical
Systems, Minnetonka, MN, USA), reported de novo
dyspareunia after 1 year in 13% and 9% of patients,
respectively [27, 28]. We detected de novo dyspareunia in
two out of eleven patients (18%), but these are small
numbers. On the other hand, the percentages of patients
having intercourse or dyspareunia at baseline and 12 months
were practically identical. In two out of seven patients
(28%) who suffered from dyspareunia at baseline, this
complaint was no longer present at 12 months. Further-
more, three out of 23 patients (13%) who were not having
intercourse at baseline had resumed this at 12 months.
These data show that prolapse itself is a cause of
dyspareunia and prolapse repair, in this case, with a fairly
large synthetic mesh, is able to resolve this problem in
some cases. These results are comparable with observations
done by the Scandinavian group, who used the short form
of the pelvic organ prolapse/urinary incontinence sexual
function questionnaire [29]. They observed an overall
deterioration of sexual function scores in women 1 year
after trocar-guided transvaginal mesh surgery. However, the
worsening was attributed to decreased scores on
behavioural-emotive and partner-related items, such as
partner inability to obtain erection. Dyspareunia neither
improved, nor worsened, as is our observation [30].
Although the rate of de novo dyspareunia seems low with
the present light-weight meshes, we should remain cautious
and await longer-term follow-up for realistic interpretations.
From a patients’ point of view, a subjective improvement
in experienced bother and quality of life is probably more
important than the objective anatomical success. This is
clearly shown by the stable percentage of patients (93%)
that experienced their situation to be much better to very
much better, 12 months after surgery than at baseline. The
improvements in the various domains of UDI, DDI, and IIQ
remain stable between 6 and 12 months and are highly
significant compared to baseline, except for the domains of
incontinence of the UDI and constipation, pain and
incontinence of the DDI, and embarrassment of the IIQ.
As mentioned before, so far, it has been our strategy not to
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tially manifest or masked stress urinary incontinence. All
patients were counselled about this strategy before surgery.
Only one patient needed and underwent a mid-urethral sling
procedure between her 6- and 12-month visits because of
unmasked stress urinary incontinence.
Inouropinion,thestrengthsofthisstudyareitsprospective
nature and the use of internationally accepted instruments of
measurementsuchasvalidatedquestionnairesandPOP-Q,the
follow-up period of 1 year, as well as the high follow-up rate
and data acquisition in all patients. A limitation of this study
on the other hand is that not all POP-Q measurements were
performed by an independent examiner.
Conclusion
The trocar-guided total tension-free vaginal mesh repair for
post-hysterectomy vaginal vault prolapse with one contin-
uous piece of polypropylene mesh is very well tolerated
and both anatomically and functionally highly effective at 6
and 12 months follow-up. Whether this procedure is more
effective and safe than other forms of prolapse surgery
remains to be determined in randomised controlled trials.
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